ArticleVirchows Archiv : an international journal of pathology2025
Rare occurrence of penoscrotal basal cell carcinoma: Clinicopathologic findings from a single institution cohort and comprehensive literature review.
Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basal cell carcinoma (BCC) is a frequently diagnosed cancer often associated with increased cumulative sun exposure. BCCs rarely occur on sun-protected areas, such as the external genitalia. Herein, we present the largest single-institution case series and comprehensive literature review of penoscrotal BCC. We performed a retrospective analysis of penoscrotal BCC cases diagnosed between 2000 and 2023 and collected information regarding demographics, risk factors, clinicopathologic features, treatment, and outcome. Available slides were reviewed by an experienced dermatopathologist and a genitourinary pathologist, and risk categories were assigned based on histologic subtype in accordance with the current World Health Organization (WHO) classification guidelines. Twenty cases of scrotal BCC and two cases of penile BCC were diagnosed during the study period. Reported risk factors included other non-melanoma skin cancer involving sun-exposed areas (42.9%) and sun-protected areas (9.5%), tobacco use (42.9%), chronic kidney disease (19%), moderate to severe sun exposure (14%), immunosuppressive/modulatory medication (9.5%), external beam radiation, and psoriasis. The median age at time of diagnosis, time to presentation, and lesion size were 69 years, 0.5 years, and 1.5 cm, respectively. Among the recognized subtypes, nodular BCC occurred most frequently (68.4%) and overall most cases (63%) were categorized as low risk. All nineteen cases with available treatment information had been treated with either Mohs (21%), excision (74%), or both (5%). No metastases were reported, and 75% of patients were alive without recurrence at follow-up. Our case series highlights important insights regarding penoscrotal BCC and increases knowledge and awareness of an unusual presentation of a common entity.
Indexed as
Identifiers
40668395What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.